On Wednesday, 11 June 2025, Zymeworks Inc. (NASDAQ:ZYME) presented at the Goldman Sachs 46th Annual ...
Wellington Management Group LLP decreased its position in Zymeworks Inc. (NYSE:ZYME - Free Report) b...
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and ...
China’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanida...
Jane Street Group LLC lessened its holdings in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by...